N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide;5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide

C71H68Cl3F3N18O9 — CID 158653862

IUPACN-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide;5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide
SMILESCC1(F)CN(C(=O)Cn2c(=O)c(C(=O)NCc3ccc(Cl)cc3)cc3c(N)c(N)cnc32)C1.Cc1nc2c(cnc3c2cc(C(=O)NCc2ccc(Cl)cc2)c(=O)n3CC(=O)N2CC(C)(F)C2)[nH]1.Cc1nc2c3cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n(CC(=O)N4CC(C)(F)C4)c3ncc2n1C
InChIInChI=1S/C25H24ClFN6O3.C24H22ClFN6O3.C22H22ClFN6O3/c1-14-30-21-17-8-18(23(35)29-9-15-4-6-16(26)7-5-15)24(36)33(22(17)28-10-19(21)31(14)3)11-20(34)32-12-25(2,27)13-32;1-13-29-18-9-27-21-16(20(18)30-13)7-17(22(34)28-8-14-3-5-15(25)6-4-14)23(35)32(21)10-19(33)31-11-24(2,26)12-31;1-22(24)10-29(11-22)17(31)9-30-19-14(18(26)16(25)8-27-19)6-15(21(30)33)20(32)28-7-12-2-4-13(23)5-3-12/h4-8,10H,9,11-13H2,1-3H3,(H,29,35);3-7,9H,8,10-12H2,1-2H3,(H,28,34)(H,29,30);2-6,8H,7,9-11,25H2,1H3,(H2,26,27)(H,28,32)
InChIKeyIBWQOHNQKIRCOD-UHFFFAOYSA-N
MW1480.79 g/mol
LogP7.20
Rot. Bonds15

About N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide;5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide

N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide;5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide (PubChem CID 158653862) has the molecular formula C71H68Cl3F3N18O9 and a molecular weight of 1480.79 g/mol. Its IUPAC name is N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide;5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide.

Molecular Properties

Compound NameN-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide;5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide
PubChem CID158653862
Molecular FormulaC71H68Cl3F3N18O9
Molecular Weight1480.79 g/mol
Exact Mass1478.44
IUPAC NameN-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide;5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide
SMILESCC1(F)CN(C(=O)Cn2c(=O)c(C(=O)NCc3ccc(Cl)cc3)cc3c(N)c(N)cnc32)C1.Cc1nc2c(cnc3c2cc(C(=O)NCc2ccc(Cl)cc2)c(=O)n3CC(=O)N2CC(C)(F)C2)[nH]1.Cc1nc2c3cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n(CC(=O)N4CC(C)(F)C4)c3ncc2n1C
InChIInChI=1S/C25H24ClFN6O3.C24H22ClFN6O3.C22H22ClFN6O3/c1-14-30-21-17-8-18(23(35)29-9-15-4-6-16(26)7-5-15)24(36)33(22(17)28-10-19(21)31(14)3)11-20(34)32-12-25(2,27)13-32;1-13-29-18-9-27-21-16(20(18)30-13)7-17(22(34)28-8-14-3-5-15(25)6-4-14)23(35)32(21)10-19(33)31-11-24(2,26)12-31;1-22(24)10-29(11-22)17(31)9-30-19-14(18(26)16(25)8-27-19)6-15(21(30)33)20(32)28-7-12-2-4-13(23)5-3-12/h4-8,10H,9,11-13H2,1-3H3,(H,29,35);3-7,9H,8,10-12H2,1-2H3,(H,28,34)(H,29,30);2-6,8H,7,9-11,25H2,1H3,(H2,26,27)(H,28,32)
InChIKeyIBWQOHNQKIRCOD-UHFFFAOYSA-N
XLogP7.20
TPSA351.44 Ų
H-Bond Donors6
H-Bond Acceptors20
Rotatable Bonds15
Heavy Atoms104
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001480.79
LogP ≤ 57.20
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1020

Analyze N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide;5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide;5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide?
The IUPAC name of N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide;5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide (CID 158653862) is N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide;5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide.
What is the SMILES notation for N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide;5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide?
The canonical SMILES for N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide;5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide is CC1(F)CN(C(=O)Cn2c(=O)c(C(=O)NCc3ccc(Cl)cc3)cc3c(N)c(N)cnc32)C1.Cc1nc2c(cnc3c2cc(C(=O)NCc2ccc(Cl)cc2)c(=O)n3CC(=O)N2CC(C)(F)C2)[nH]1.Cc1nc2c3cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n(CC(=O)N4CC(C)(F)C4)c3ncc2n1C.
What is the InChIKey of N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide;5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide?
The InChIKey is IBWQOHNQKIRCOD-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H24ClFN6O3.C24H22ClFN6O3.C22H22ClFN6O3/c1-14-30-21-17-8-18(23(35)29-9-15-4-6-16(26)7-5-15)24(36)33(22(17)28-10-19(21)31(14)3)11-20(34)32-12-25(2,27)13-32;1-13-29-18-9-27-21-16(20(18)30-13)7-17(22(34)28-8-14-3-5-15(25)6-4-14)23(35)32(21)10-19(33)31-11-24(2,26)12-31;1-22(24)10-29(11-22)17(31)9-30-19-14(18(26)16(25)8-27-19)6-15(21(30)33)20(32)28-7-12-2-4-13(23)5-3-12/h4-8,10H,9,11-13H2,1-3H3,(H,29,35);3-7,9H,8,10-12H2,1-2H3,(H,28,34)(H,29,30);2-6,8H,7,9-11,25H2,1H3,(H2,26,27)(H,28,32).
What are the key properties of N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide;5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide?
N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide;5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide has a molecular weight of 1480.79 g/mol, XLogP of 7.20, 15 rotatable bonds, 6 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-methyl-7-oxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide;5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide is sourced from PubChem (CID 158653862), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).